NYMC > News and Events > Press Room > 2015 Press Archives

NYMC Welcomes New BioInc Client

BioInc@NYMC occupies a 10,000 square-foot wing of a 129,000 square-foot campus building.

Date: April 15, 2015
Media Contact:

Jennifer Riekert, M.B.A.
Vice President of Communications
New York Medical College
(914) 594-4552
Jennifer_Riekert@nymc.edu

Four LLC to Become Fourth Member of the College’s Innovative Biotech Incubator

Valhalla, N.Y. – April 14, 2015 – New York Medical College (NYMC) today welcomed Four LLC—a nutrition, health and fitness consumer product company—as a new client of BioInc@NYMC, the College’s biotechnology incubator. Opened in October 2014, BioInc@NYMC operates with the aim of finding new ways to prevent and treat human disease and disability, a quality that is shared with the type of clients the incubator houses and attracts.

Four LLC was founded in 2013 to research, create and market nutrition products based on life science patents. Four LLC’s products—currently under development— aim to curb food cravings, creating a new category in sustainable nutrition. The first product launch is expected in early 2016.

“Four LLC is a welcome addition to BioInc@NYMC,” said Randi Schwartz, M.B.A., interim director of BioInc@NYMC and associate dean for academic administration. “The company’s research in sustainable nutrition will supplement the innovative work already taking place at the incubator, which continues to generate new knowledge about biomedicine while serving as an economic engine for the local community.”

“We are excited and honored to join BioInc@NYMC,” said Arianne Perry, Chief Operating Officer of Four LLC. “The incubator’s best-in-class facilities and resources are already accelerating our research and development. Our product will help people live healthier, happier lives and we are thankful for the support of NYMC, Startup New York, and the Hudson Valley community in bringing our product to market.”

Four LLC will be the fourth occupant of BioInc@NYMC, joining Conversion Energy Enterprises, a corporation that develops and prototypes laser products for medical applications; MB Group USA, a supplier of products derived from rare fruits for health purposes; and MOE Medical Devices LLC, a maker of cold electrical plasma therapeutics. The incubator’s convenient location, with its proximity to New York City, allows NYMC to go beyond providing start-ups with affordable space, giving them access to invaluable resources, such as cutting-edge core facilities and collaboration with scientists and clinicians.

A top regional economic priority from 2011 to 2013, BioInc@NYMC is a public-private enterprise, combining resources from the federal government, New York State, Westchester County and NYMC, and is the only incubator of its kind in the region that is directly co-located with a health science's university campus. It has been approved by Start-Up NY and has received the multi-year Mid-Hudson Innovation Hot Spot award granted by the New York State Regional Economic Development Council.

BioInc@NYMC occupies a 10,000 square-foot wing of a 129,000 square-foot campus building. An initial build-out of 4,500 square feet with finished laboratories, offices and shared infrastructure is ready for immediate occupancy. Development of the remaining space is planned to proceed as the initial spaces are filled. Additional available space in the same building (50,000-60,000 square feet) is ideal for future growth of the incubator or related biomedical research activities.

About New York Medical College
Founded in 1860, NYMC is one of the oldest and largest health sciences universities in the country with more than 1,400 students, 1,300 residents and clinical fellows, nearly 3,000 faculty members, and 15,000 living alumni. The College, which joined the Touro College and University System in 2011, is located in Westchester County, New York, and offers advanced degrees from the School of Medicine, the Graduate School of Basic Medical Sciences, and the School of Health Sciences and Practice. The College manages more than $36 million in research and other sponsored programs, notably in the areas of cancer, cardiovascular disease, infectious diseases, kidney disease, the neurosciences, disaster medicine, and vaccine development.

With a network of affiliated hospitals that includes large urban medical centers, small suburban clinics and high-tech regional tertiary care facilities, NYMC provides a wide variety of clinical training opportunities throughout the tri-state region for medical students, residents, and other health providers.

Tagged:
bioinc